IL22 and polycystic ovary syndrome: Recently, it has been suggested that the gut microbiota is associated with metabolic disorders in women with PCOS, and that its modification alters bile acid metabolism and/or increases IL-22 levels which may be of value for the treatment of PCOS 29.